Company intelligence / Profile preview

Nu Skin

Provo, Utah, United Statesnuskin.com ↗

Ownership: Public · NUS
Employees: ~4500
Development stage: Commercial

Overview

Nu Skin develops and markets premium personal care, anti-aging skincare devices, nutritional supplements, and wellness solutions globally. It operates through direct sales/multilevel marketing. Its portfolio includes brands like ageLOC and Pharmanex. The company has a history of innovation in cosmetic science but does not conduct pharmaceutical clinical trials or develop prescription drugs.

Industry: Food & Nutrition

Partnerships

No major pharma/biotech partnerships reported; focus on distribution partners/distributors.

Financials

Market cap: $219M
Total revenue: $1.5B
Enterprise value: $306.6M

Beyond the preview

Go deeper on Nu Skin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nu Skin.